A practical reference on GHRH analog: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-05-24. Anything still debated is marked as such rather than presented as settled.
Reported half-lives differ widely between the two variants and between species. Values for the albumin-binding form are usually expressed in days, while the unconjugated form is measured in minutes to a few hours. Sampling schedules, assay sensitivity, and route of administration all influence the numbers, which limits direct comparison across studies. Whether sustained receptor occupancy produces different downstream effects from pulsatile stimulation remains an open question in the published work. Claims about relative potency should therefore be read alongside the specific study design that produced them.
Lyophilised powder is the usual supplied form. The material is hygroscopic, so vials are typically equilibrated to room temperature before opening in order to prevent condensation on the contents. Long-term storage is generally described at minus twenty degrees Celsius or colder, protected from light and moisture. Repeated freeze-thaw cycles are avoided because they promote aggregation and loss of soluble material. A reconstituted solution is considerably less stable than the dry powder and is normally kept refrigerated for short periods only.
Identity and purity are assessed mainly by reversed-phase high-performance liquid chromatography combined with mass spectrometry. The chromatographic separation resolves the target peptide from truncation products and from species carrying oxidised residues, while mass measurement confirms the expected molecular mass. Because the two common variants differ by roughly 280 daltons, a mass determination distinguishes them unambiguously. Purity is often quoted as a percentage of total peak area, although that figure depends on the detection wavelength and the integration method applied.
Both forms act at the pituitary receptor for growth hormone-releasing hormone and increase growth hormone output, which in turn raises insulin-like growth factor 1. A long-acting analog produces sustained rather than pulsatile stimulation, and the physiological consequences of that pattern are not fully settled. Published human data on the extended form remain limited, and much of what circulates in discussion traces to early company reports rather than independent replication. How sustained exposure affects normal feedback remains an open question.
The distinguishing feature of the DAC form is a maleimide-containing group that reacts with the free thiol of cysteine-34 on human serum albumin. This reaction forms a covalent bond without enzymatic assistance, and it takes place after the peptide enters the bloodstream. Because albumin is abundant and long-lived, the attached peptide is carried through circulation far longer than an unmodified fragment would survive. The chemistry is a deliberate pharmacokinetic strategy rather than a change to receptor activity.
Enzymatic protection is a separate mechanism from plasma protein binding. The four substitutions in the backbone reduce recognition by dipeptidyl peptidase IV, which normally cleaves the natural hormone within minutes. Without the reactive group, this resistance still yields only a short window of activity, generally reported in the range of tens of minutes. With it, reported half-lives in early human work extended to several days. The size of that gap is the main practical distinction between the two materials.
| Property | Value | Notes |
|---|---|---|
| Appearance as powder | White to off-white solid | Minor batch-to-batch variation is normal |
| Solubility class | Soluble in water and aqueous buffers | Dissolution can be slowed by aggregates |
| Typical storage temperature | Minus 20 degrees Celsius or below | Protected from light and moisture |
| Storage after reconstitution | 2 to 8 degrees Celsius, short term | Longer holding requires freezing |
| Common analytical method | Reversed-phase HPLC with mass spectrometry | Used for purity and identity confirmation |
CJC-1295 belongs to a family of synthetic peptides modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound is built from the first twenty-nine amino acids of the natural human sequence, a fragment that retains full receptor binding capacity. Native growth hormone-releasing hormone is degraded quickly in circulation, so the fragment alone has limited practical value. Early work therefore focused on chemical modifications that preserve receptor binding while slowing enzymatic breakdown. The result is a molecule described in the literature as a long-acting analog of the natural hormone.
Two forms circulate under the CJC-1295 name, and they differ by a single appended group. The version without a drug affinity complex carries four substitutions along the peptide chain, including a D-alanine near the amino terminus and replacements at three other positions. These changes block the enzyme dipeptidyl peptidase IV and remove a methionine residue that is prone to oxidation. The modified fragment is frequently labeled MOD GRF 1-29. Naming conventions are inconsistent across informal sources, which is a common source of confusion.
CJC-1295 is a synthetic peptide belonging to the growth hormone-releasing hormone analog family. It comprises twenty-nine amino acid residues derived from the N-terminal region of natural GHRH. The molecule incorporates several non-natural substitutions that increase resistance to enzymatic degradation. These modifications extend its activity compared with the native hormone fragment. Researchers use it to study pituitary growth hormone secretion in laboratory and clinical settings. This compound is distinct from native GHRH in its stability profile.
Two principal forms appear in the literature and in research supply. One carries a drug affinity complex, a maleimide-based group that forms a covalent bond with circulating albumin. This linkage slows clearance and produces a long-lasting elevation of peptide levels. The other form lacks that group and is often labeled MOD GRF(1-29). It has a much shorter circulation time. Both variants retain the same core receptor-binding sequence. Reported half-lives differ substantially between the two.
Clearance profiles diverge sharply between the two versions. The albumin-binding molecule stays in plasma for several days, whereas the unmodified analog is largely gone within about half an hour in reported work. Cleavage by dipeptidyl peptidase IV is a major contributor to the short life of the unmodified sequence. These gaps mean the two versions cannot be substituted for each other in study design or in reading results side by side.
Reports on this compound commonly follow serum growth hormone and insulin-like growth factor 1 across defined time windows. Protocols differ in sampling frequency, assay platform, and participant characteristics, which makes direct comparison between publications difficult. Some work focuses on pulsatile release patterns instead of average concentrations. Whether repeated exposure alters endogenous hormone rhythms over long periods remains an open question, and the formal literature is thinner than the volume of informal commentary implies.
Once in circulation, the peptide binds the growth hormone-releasing hormone receptor displayed on pituitary somatotroph cells. Receptor activation couples to Gs proteins, elevates intracellular cyclic AMP, and drives protein kinase A signaling inside the cell. That cascade increases discharge of growth hormone into the bloodstream. The analog therefore operates through a receptor pathway that already exists for the body's own releasing hormone, rather than through an engineered artificial target.
== Construction == Incandescent light bulbs consist of an air-tight glass enclosure (the envelope, or bulb) with a filament of tungsten wire inside the bulb, through which an electric current is passed. Contact wires and a base with two (or more) conductors provide electrical connections to the filament. Incandescent light bulbs usually contain a stem or glass mount anchored to the bulb's base that allows the electrical contacts to run through the envelope without air or gas leaks. Small wires embedded in the stem in turn support the filament and its lead wires. An electric current heats the filament to typically 2,000 to 3,300 K (1,730 to 3,030 °C; 3,140 to 5,480 °F), well below tungsten's melting point of 3,695 K (3,422 °C; 6,191 °F). Filament temperatures depend on the filament type, shape, size, and amount of current drawn. The heated filament emits light that approximates a continuous spectrum. The useful part of the emitted energy is visible light, but most energy is given off as heat in the near-infrared wavelengths.
A frameshift mutation is caused by insertion or deletion of a number of nucleotides that is not evenly divisible by three from a DNA sequence. Due to the triplet nature of gene expression by codons, the insertion or deletion can disrupt the reading frame, or the grouping of the codons, resulting in a completely different translation from the original. The earlier in the sequence the deletion or insertion occurs, the more altered the protein produced is. (For example, the code CCU GAC UAC CUA codes for the amino acids proline, aspartic acid, tyrosine, and leucine. If the U in CCU was deleted, the resulting sequence would be CCG ACU ACC UAx, which would instead code for proline, threonine, threonine, and part of another amino acid or perhaps a stop codon (where the x stands for the following nucleotide).) By contrast, any insertion or deletion that is evenly divisible by three is termed an in-frame mutation. A point substitution mutation results in a change in a single nucleotide and can be either synonymous or nonsynonymous. A synonymous substitution replaces a codon with another codon that codes for the same amino acid, so that the produced amino acid sequence is not modified. Synonymous mutations occur due to the degenerate nature of the genetic code. If this mutation does not result in any phenotypic effects, then it is called silent, but not all synonymous substitutions are silent.
=== 2014 === On January 22, 2014, European Southern Observatory became the first scientific organization to deliver Ultra HD footage at regular intervals. On May 6, 2014, France announced DVB-T2 tests in Paris for Ultra HD HEVC broadcast with objectives to replace by 2020 the current DVB-T MPEG4 HD national broadcast. On May 26, 2014, satellite operator Eutelsat announced the launch of Europe's first Ultra HD demo channel in HEVC, broadcasting at 50 fps. The channel is available on the Hot Bird satellites and can be watched by viewers with 4K TVs equipped with DVB-S2 demodulators and HEVC decoders. In June 2014, the FIFA World Cup of that year (held in Brazil) became the first shot entirely in 4K Ultra HD, by Sony. The European Broadcasting Union (EBU) broadcast matches of the FIFA World Cup to audiences in North America, Latin America, Europe and Asia in Ultra HD via SES' NSS-7 and SES-6 satellites. Indian satellite TV provider unveils its plan to launch 4K UHD service early in 2015 and showcased live FIFA World Cup quarter final match in 4K UHD through Sony Entertainment Television Sony SIX. On June 24, 2014, the CEA updated the guidelines for Ultra High-Definition and released guidelines for Connected Ultra High-Definition, adding support for internet video delivered with HEVC. The CEA is developing a UHD logo for voluntary use by companies that make products that meet CEA guidelines. The CEA also clarified that "Ultra High-Definition", "Ultra HD", or "UHD" can be used with other modifiers and gave an example with "Ultra High-Definition TV 4K".
CoA + acetyl-[acyl-carrier-protein] Thus, the two substrates of this enzyme are acetyl-CoA and acyl carrier protein, whereas its two products are CoA and acetyl-acyl-carrier-protein. This enzyme belongs to the family of transferases, specifically those acyltransferases transferring groups other than aminoacyl groups. The systematic name of this enzyme class is acetyl-CoA:[acyl-carrier-protein] S-acetyltransferase. Other names in common use include acetyl coenzyme A-acyl-carrier-protein transacylase, acetyl-CoA:ACP transacylase, [acyl-carrier-protein]acetyltransferase, [ACP]acetyltransferase, and ACAT. This enzyme participates in fatty acid biosynthesis.
A glucoside is a glycoside that is chemically derived from glucose. Glucosides are common in plants, but rare in animals. Glucose is produced when a glucoside is hydrolysed by purely chemical means, or decomposed by fermentation or enzymes. The name was originally given to plant products of this nature, in which the other part of the molecule was, in the greater number of cases, an aromatic aldehydic or phenolic compound (exceptions are Jinigrin and Jalapin or Scammonin). It has now been extended to include synthetic ethers, such as those obtained by acting on alcoholic glucose solutions with hydrochloric acid, and also the polysaccharoses, e.g. cane sugar, which appear to be ethers also. Although glucose is the most common sugar present in glucosides, many are known which yield rhamnose or iso-dulcite; these may be termed pentosides. Much attention has been given to the non-sugar parts (aglycone) of the molecules; the constitutions of many have been determined, and the compounds synthesized; and in some cases the preparation of the synthetic glucoside effected. The simplest glucosides are the alkyl ethers which have been obtained by reacting hydrochloric acid on alcoholic glucose solutions. A better method of preparation is to dissolve solid anhydrous glucose in methanol containing hydrochloric acid. A mixture of alpha- and beta-methylglucoside results. The classification of glucosides is a matter of some intricacy.
Sources: en.wikipedia.org
=== Relation of PIDD1 to centrosomes === Recent investigations reveal that CASP2 activation, which is dependent on PIDD1, does not lead to cell death or activate p53 in reaction to DNA damage (such as that induced by doxorubicin) or during prolonged mitotic arrest (as observed with taxol treatment). In contrast, the p53 activation linked to centrosome amplification—a process that can occur following failed cytokinesis—undoubtedly depends on the Caspase-2−PIDDosome complex. Notably, PIDD1 appears to be integral in assessing the quantity of mature mother centrioles, utilizing a mechanism that has yet to be fully clarified. Furthermore, PIDD1 is situated at the distal ends of mature centrosomes within normal cells, suggesting its potential role in regulating centrosomal functions. The assembly of the Caspase-2−PIDDosome can be triggered by the presence of multiple mature centrioles with appendages. This activation leads to CASP2-mediated cleavage of MDM2, resulting in the accumulation of p53 and subsequent cell cycle arrest mediated by p21. Notably, these processes occur without causing significant cell death. Similarly, the depletion of centrosomes undermines the effectiveness of this pathway during instances of cytokinesis failure. In contrast, overexpressing polo-like kinase 4 (PLK4), which promotes the formation of additional centrosomes, is sufficient to activate the pathway even when cytokinesis is not compromised.
US policy regarding media freedom was much more restrictive than in the Vietnam War. The policy had been spelled out in a Pentagon document entitled Annex Foxtrot. Most of the press information came from briefings organized by the military. Only selected journalists were allowed to visit the front lines or conduct interviews with soldiers. Those visits were always conducted in the presence of officers, and were subject to both prior approval by the military and censorship afterward. This was ostensibly to protect sensitive information from being revealed to Iraq. This policy was heavily influenced by the military's experience with the Vietnam War, in which public opposition within the US grew throughout the war's course. It was not only the limitation of information in the Middle East; media were also restricting what was shown about the war with more graphic depictions like Ken Jarecke's image of a burnt Iraqi soldier being pulled from the American AP wire whereas in Europe it was given extensive coverage. Two BBC journalists, John Simpson and Bob Simpson (no relation), defied their editors and remained in Baghdad to report on the war's progress. They were responsible for a report which included an "infamous cruise missile that travelled down a street and turned left at a traffic light." Alternative media outlets provided views opposing the war. Deep Dish Television compiled segments from independent producers in the US and abroad, and produced a 10-hour series that was distributed internationally, called The Gulf Crisis TV Project.
=== Behavior === The primary non-cellular functions of tau is to negatively regulate long-term memory and to facilitate habituation (a form of non-associative learning), two higher and more integrated physiological functions. Since regulation of tau is critical for memory, this could explain the linkage between tauopathies and cognitive impairment. In mice, while the reported tau knockout strains present without overt phenotype when young, when aged, they show some muscle weakness, hyperactivity, and impaired fear conditioning. However, neither spatial learning in mice, nor short-term memory (learning) in Drosophila seems to be affected by the absence of tau. In addition, tau knockout mice have abnormal sleep-wake cycle, with increased wakefulness periods and decreased non-rapid eye movements (NREM) sleep time.
Seeded second at the Italian Open, he reached the semifinals defeating Cristian Garín in the quarterfinals. In the semifinals, he faced fourth seed, Stefanos Tsitsipas, again for the third consecutive time at this Masters level in the clay court season. He lost his semifinal match to Tsitsipas in three sets. Seeded third at the French Open, Zverev matched his semifinal result from the previous year, defeating sixth seed, Carlos Alcaraz, in the quarterfinals in what was his first top-10 victory at a major after 12 attempts. In his semifinal match against fifth seed, former world No. 1, and 13 time Roland Garros champion, Rafael Nadal, he retired 3 hours and 13 minutes into the match after rolling his right ankle and tearing all three lateral ligaments. He was rolled off the court in a wheelchair. Zverev informed that the injury would cause him to miss the 2022 Wimbledon Championships and on 8 June 2022 underwent surgery to repair the torn ligaments in his ankle. Despite his exit at Roland Garros, he reached a career-high ranking of world No. 2 on 13 June 2022. In September, he was due to return for the Davis Cup play but suffered a new injury, a bone edema, and withdrew from competition for the rest of the season. Zverev ended the year ranked 12, his lowest in five years, when he debuted in the top 10 and remained a fixture there.
Sources: en.wikipedia.org
=== Peroxide stress response === In response to an increased flux of hydrogen peroxide and other organic peroxides such as tert-butyl hydroperoxide and cumene hydroperoxide, peroxide stimulon gets activated. Studies of E. coli response to H2O2 have shown that exposure to H2O2 elevated mRNA levels of 140 genes, of which 30 genes are members of the OxyR regulon. The genes include many genes coding for metabolic enzymes and antioxidant enzymes demonstrating the role of these enzymes in reorganization of metabolism under stress conditions.
Most novel drug candidates (NCEs) fail during drug development, either because they have unacceptable toxicity or because they simply do not prove efficacy on the targeted disease, as shown in Phase II–III clinical trials. Critical reviews of drug development programs indicate that Phase II–III clinical trials fail due mainly to unknown toxic side effects (50% failure of Phase II cardiology trials), and because of inadequate financing, trial design weaknesses, or poor trial execution. A study covering clinical research in the 1980–1990s found that only 21.5% of drug candidates that started Phase I trials were eventually approved for marketing. During 2006–2015, the success rate of obtaining approval from Phase I to successful Phase III trials was under 10% on average, and 16% specifically for vaccines. The high failure rates associated with pharmaceutical development are referred to as an "attrition rate", requiring decisions during the early stages of drug development to "kill" projects early to avoid costly failures.
=== Limitation of structure databases === Structure databases are orders of magnitude larger than spectral libraries but still incomplete. It is understood that not every existing biomolecule is or will be contained in structure databases. For these instances, SIRIUS offers several solutions:
Sources: en.wikipedia.org
Chromatography reports how much material elutes as a single peak but does not confirm what that material is. Mass spectrometry supplies the molecular mass, which is characteristic of a given sequence and its modifications. Together the two methods support both a purity figure and an identity claim.
Hydrolysis, oxidation of susceptible residues, and aggregation all contribute, and their rates depend on pH, temperature, and concentration. Dissolved oxygen and trace metal ions accelerate oxidation. Keeping solutions cold, dilute, and free of unnecessary handling reduces these pathways.
Not always, because the value depends on the detection wavelength, the gradient, and how peak areas are integrated. A figure of ninety-eight percent from one laboratory may not mean the same as the same number from another. Comparing full chromatograms and mass spectra is more informative than comparing a single number.
A maleimide moiety reacts with the thiol of cysteine-34, forming a covalent bond. The reaction occurs in circulation without enzymatic catalysis.